Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

WINDLAS BIOTECH LTD.

NSE : WINDLASBSE : 543329ISIN CODE : INE0H5O01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE552.200.3 (+0.05 %)
PREV CLOSE () 551.90
OPEN PRICE () 559.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3997
TODAY'S LOW / HIGH ()547.65 568.65
52 WK LOW / HIGH ()250.85 590
NSE550.65-2.1 (-0.38 %)
PREV CLOSE() 552.75
OPEN PRICE () 547.00
BID PRICE (QTY) 550.65 (163)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 106165
TODAY'S LOW / HIGH() 544.05 570.90
52 WK LOW / HIGH ()251 590.85
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2001

Management Info :

Vivek Dhariwal - Chairman Hitesh Windlass - Managing Director

Registered Office :

Address : 40 / 1,Mohabewala Industrial Area,,
Dehradun,
Uttarakhand-248110

Phone : 0135-6608000-30

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Apr Windlas Biotech informs about analyst
Pursuant to the relevant provisions of SEBI (Listing Obligations and Dis..
03Apr Windlas Biotech surges on commissionin
Windlas Biotech is currently trading at Rs. 562.85, up by 12.90 points o..
02Apr Windlas Biotech informs about press re
Windlas Biotech has informed that it attached press release on ‘Windlas..
02Apr Windlas Biotech commissions injectable
Windlas Biotech has commissioned its state-of-the-art injectable facilit..
20Feb Windlas Biotech informs about analyst
Pursuant to the relevant provisions of SEBI (Listing Obligations and Dis..
Financials
in Millions
QTR Dec 23 ANNUAL 23
Net Profit150.98426.44
Gross Profit 198.07 570.57
Operating Profit 235.01702.07
Net Sales 1622.135130.83
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8679.45 (4.27%)
M.Cap ( in Cr)
19989.31
Abbott India (BSE)
 26604.35 (0.71%)
M.Cap ( in Cr)
56532.39
Amrutanjan Healthcar (BSE)
 786.60 (12.70%)
M.Cap ( in Cr)
2274.11
NGL Fine-Chem (BSE)
 2634.60 (3.41%)
M.Cap ( in Cr)
1627.66
Dr. Reddy's Lab (BSE)
 6288.30 (1.34%)
M.Cap ( in Cr)
104900.33
Shareholding Pattern
PROMOTERS 62.82%
NON-INSTITUTION 24.19%
MUTUAL FUNDS/UTI 10.37%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74611.11128.33 (0.17%)
NIFTY22648.2043.35 (0.19%)
Dow Jones 37903.2987.37 (0.23%)
Nasdaq 15605.48-52.34 (-0.33%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI